CCS PhD student profile: Mahtab Parvaresh

Mahtab Parvaresh at the 2017 CCS 3MT heats.

 by Matt Jane                                                             
Mahtab Parvaresh is a PhD student in the Natural Killer (NK) Cell Biology Laboratory in the Department of Immunology. She is supervised by Dr Dan Andrews. Mahtab completed a Bachelor of Biotechnology at RMIT and then went on to complete her Honours at Monash University.

Grow, Dan! Movember is here and so is your chance to contribute

Dan Andrews (Immunology) is doing Movember again this year to raise money for men's health research. He is very high-brow in this picture and adding the Mo-Bro look. Grow for broke, Dan!

Dan did this 3 years ago at the Peter Mac and had a competition where the highest donor got to choose the colour he would dye his  Mo at the end. He will run the same thing here and - bonus! - will also allow the winner to write something on his head for the last day (must be OK to be seen in public!!! 'I am a stupid head' is apparently allowed.....).

See the link for donations and the coloured Mo from last time.

https://au.movember.com/mospace/13407610

Immunology "Cutting Edge" Friday seminars kicking off 5 Feb

Maria Demaria at the 2015 Day
of Immunology GTAC workshop

"Cutting Edge Immunology” sessions were initiated in 2015, in which an important new paper in the broad field of immunology is discussed each week by young scientists as part of their training in reading, presenting and discussing new and significant research. This continues in 2016 and the first session is on Friday 5 Feb.

Welcome to Dr Dan Andrews, Department of Immunology

Dr Daniel Andrews is a Senior Research Fellow and laboratory head for the Natural Killer (NK) Cell Biology Laboratory in the Department of Immunology. He heads the newly formed NK cell Biology Laboratory focuses on the interaction between NK cell receptors and non-classical MHC. The focus is on understanding the biochemistry, cell biology and immune responses associated with these interactions.

Immune detection and eradication or control of cancer and cancer immunotherapies are based in part on the idea that tumour-specific white blood cells can protect the body from tumour development, growth and metastases. While strong evidence supports this, the means by which these white cells first recognize the cancerous tissue is largely unknown. We are studying a new family of white blood cell receptors that may be important in this recognition, either naturally or following therapy.
See more: www.med.monash.edu.au/immunology/staff/andrews-dan.html